FULL CIRCLES THERAPEUTICS
Live / Applied — Statement of use — non-final action mailed (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 22 Apr 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981362
- Mark type
- Stylized text
- Filed
- 22 Apr 2021
- Published for opposition
- 22 Mar 2022
- Attorney of record
- Britt L. Anderson
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, custom donor genetic material in the nature of human cells for use in genome modification; Biological preparations for use in the genetic treatment of pathological medical conditions, namely, cancer, neurological diseases, autoimmune diseases, and genetic disorders
Owner
- FULL CIRCLES THERAPEUTICS, INC., CAMBRIDGE, MA, US
- FULL CIRCLES THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Stellate Biotherapeutics, Inc., Cambridge, MA, US
- Stellate Biotherapeutics, Inc., Cambridge, MA, US
Prosecution history
- 10 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Mar 2026 — NON-FINAL ACTION E-MAILED
- 10 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 20 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 12 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Dec 2025 — FINAL REFUSAL E-MAILED
- 12 Dec 2025 — SU - FINAL REFUSAL - WRITTEN
- 10 Nov 2025 — ASSIGNED TO EXAMINER
- 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Sept 2025 — ASSIGNED TO LIE